Cytokinetics – Health Equity in Cardiovascular Disease Corporate Giving Program (2026)

3 Min Read

National Charitable Support for Cardiovascular Health Equity Initiatives

Cytokinetics’ Corporate Giving Program provides charitable donations to qualified 501(c)(3) organizations supporting equitable healthcare initiatives for cardiovascular disease in underserved communities. Through this national funding priority, Cytokinetics seeks to help reduce disparities and support community-based approaches that improve access, awareness, and support for people affected by cardiovascular disease.

Organization: Cytokinetics
Support Type: Corporate charitable donations
Geographic Focus: U.S.-based national initiatives or community-based programs
Deadline: August 3, 2026

New to corporate grant fundraising?
Read our Corporate Grants for Nonprofits: Ultimate Guide to learn how corporate funding works.

About the Funder

Cytokinetics is a biopharmaceutical company focused on developing potential medicines for diseases affecting muscle performance. Through its Corporate Giving Program, Cytokinetics supports nonprofit organizations whose missions and programs align with its corporate giving priorities.

The company’s giving program includes support for diversity in science education, health equity in cardiovascular disease, and local community support. This opportunity focuses specifically on Cytokinetics’ national health equity priority related to cardiovascular disease.

What This Program Supports

The Health Equity in Cardiovascular Disease funding priority supports equitable healthcare initiatives for cardiovascular disease in underserved communities. The goal is to help reduce disparities and support programs that improve awareness, access, and community-based support.

Eligible activities may include:

Public health programs related to cardiovascular disease
Awareness and education initiatives
Non-healthcare community support programs
Community-led solutions
Programs that improve access to basic services
New or innovative approaches to reducing cardiovascular health disparities
Initiatives serving underserved communities affected by cardiovascular disease

Geographic Focus

This funding priority has a national focus. Eligible requests may include:

U.S.-based national initiatives
Community-based programs in the United States
Programs serving underserved communities affected by cardiovascular disease

Eligibility

Cytokinetics provides charitable donations to qualified 501(c)(3) organizations in the United States.

Eligible organizations must:

Be a qualified 501(c)(3) organization
Be based in the United States
Align with Cytokinetics’ Health Equity in Cardiovascular Disease priority
Serve underserved communities or populations affected by cardiovascular disease disparities
Meet Cytokinetics’ funding and eligibility criteria
Submit a complete application online during the open call period

Cytokinetics notes that eligible organizations must not be engaged in, or directly involved in, the practice of healthcare.

Recognition / Benefit Restrictions

No benefit may be provided to Cytokinetics in return for support, unless the benefit is incidental in nature. For example, fair recognition of the company name on a list of donors may be acceptable.

Funding Amounts

Cytokinetics does not publish standard award amounts for this corporate giving program. Donation amounts may vary based on program alignment, proposal strength, available funding, and potential community impact.

Timeline

📅 Application Opens: June 8, 2026
📅 Application Deadline: August 3, 2026
📅 Program Type: Open call for proposals

Application / Request Process

Applicants must submit a complete application online during the open call for proposals. Organizations should review Cytokinetics’ Funding & Application Guidelines and ensure their request clearly aligns with the company’s Health Equity in Cardiovascular Disease priority.

Strong applications should clearly describe:

The cardiovascular disease-related need being addressed
The underserved community or population served
How the program helps reduce disparities
Whether the initiative is national or community-based
Expected outcomes or community impact
How the organization’s work aligns with Cytokinetics’ corporate giving priorities

Apply / Learn More:
➡️ https://cytokinetics.com/responsibility/grants-and-giving-programs/corporate-giving-program/

Questions may be directed to: grants@cytokinetics.com

Why This Opportunity Is a Good Fit

This opportunity is a strong fit for organizations that:

Work to reduce cardiovascular disease disparities
Serve underserved communities in the United States
Provide public health, awareness, education, or community support programs
Offer community-led or innovative approaches to health equity
Can demonstrate clear alignment with cardiovascular health equity
Have qualified 501(c)(3) status

Cytokinetics’ Health Equity in Cardiovascular Disease giving priority is best suited for nonprofits addressing cardiovascular disease disparities through public health, education, community support, and access-focused strategies.

Corporate Grants Guide Notes

Review Type: Competitive open call
Application Window: June 8–August 3, 2026
Deadline: August 3, 2026
Best Suited For: Cardiovascular health equity, public health awareness, community-led health initiatives, and programs serving underserved communities
Geographic Fit: U.S.-based national initiatives or community-based programs